Healthcare Triangle faces Nasdaq delisting after failing $1 minimum bid price rule
HCTI•Healthcare Triangle received a Nasdaq delisting determination after failing the $1 minimum bid price rule; the company plans to request a hearings panel review.
1. Delisting determination
Nasdaq issued the determination after Healthcare Triangle received a notice on Oct. 1, 2026, for failing the $1 minimum bid price rule. Nasdaq cited the company’s ineligibility for a cure period because of reverse splits totaling 1-for-14,940. Without an appeal by Oct. 8, trading would be suspended at the open on Oct. 12, followed by a Form 25-NSE filing; a hearings panel review request would stay the suspension pending a decision.
2. Company plans review
Management expects to present a compliance plan that could include another reverse stock split.
